604 related articles for article (PubMed ID: 15946912)
21. Gene polymorphism of the renin-angiotensin system and progression of diabetic nephropathy.
Orisio S
J Nephrol; 1999; 12(1):9-17. PubMed ID: 10202997
[TBL] [Abstract][Full Text] [Related]
22. Renin-angiotensin system polymorphisms and renal graft function in renal transplant recipients.
Argani H; Noroozianavval M; Aghaeishahsavari M; Veisi P; Rashtchizadeh N; Ghorbanihaghjo A; Bonyadi M; Asgarzadeh M; Hamzeiy H
Saudi Med J; 2007 Oct; 28(10):1496-502. PubMed ID: 17914507
[TBL] [Abstract][Full Text] [Related]
23. Recurrent in-stent restenosis is not associated with the angiotensin-converting enzyme D/I, angiotensinogen Thr174Met and Met235Thr, and the angiotensin-II receptor 1 A1166C polymorphism.
Gross CM; Perrot A; Geier C; Posch MG; Hassfeld S; Kramer J; Schmidt S; Derer W; Dietz R; Ozcelik C
J Invasive Cardiol; 2007 Jun; 19(6):261-4. PubMed ID: 17541127
[TBL] [Abstract][Full Text] [Related]
24. No association between renin-angiotensin system gene polymorphisms and early and long-term allograft dysfunction in kidney transplant recipients.
Slowinski T; Diehr P; Kleemann P; Fritsche L; Renders L; Budde K; Hauser IA; Neumayer HH; Hocher B
Nephrol Dial Transplant; 2004 Nov; 19(11):2846-51. PubMed ID: 15353577
[TBL] [Abstract][Full Text] [Related]
25. ACE variants interact with the RAS pathway to confer risk and protection against type 2 diabetic nephropathy.
Ahluwalia TS; Ahuja M; Rai TS; Kohli HS; Bhansali A; Sud K; Khullar M
DNA Cell Biol; 2009 Mar; 28(3):141-50. PubMed ID: 19108684
[TBL] [Abstract][Full Text] [Related]
26. Genetic variation and activity of the renin-angiotensin system and severe hypoglycemia in type 1 diabetes.
Pedersen-Bjergaard U; Dhamrait SS; Sethi AA; Frandsen E; Nordestgaard BG; Montgomery HE; Pramming S; Hougaard P; Thorsteinsson B
Am J Med; 2008 Mar; 121(3):246.e1-8. PubMed ID: 18328310
[TBL] [Abstract][Full Text] [Related]
27. Population-based case-control study of renin-angiotensin system genes polymorphisms and hypertension among Hispanics.
Bautista LE; Vargas CI; Oróstegui M; Gamarra G
Hypertens Res; 2008 Mar; 31(3):401-8. PubMed ID: 18497458
[TBL] [Abstract][Full Text] [Related]
28. Renin-angiotensin system gene polymorphisms influence blood pressure and the response to angiotensin converting enzyme inhibition.
Hingorani AD; Jia H; Stevens PA; Hopper R; Dickerson JE; Brown MJ
J Hypertens; 1995 Dec; 13(12 Pt 2):1602-9. PubMed ID: 8903618
[TBL] [Abstract][Full Text] [Related]
29. Renin-angiotensin-system gene polymorphisms and depression.
Saab YB; Gard PR; Yeoman MS; Mfarrej B; El-Moalem H; Ingram MJ
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1113-8. PubMed ID: 17499413
[TBL] [Abstract][Full Text] [Related]
30. Enalapril and losartan affect lipid peroxidation in renal transplant recipients with renin-angiotensin system polymorphisms.
Rashtchizadeh N; Aghaeishahsavari M; Argani H; Noroozianavval M; Veisi P; Ghorbanihaghjo A
Clin Biochem; 2007 Feb; 40(3-4):194-200. PubMed ID: 17222813
[TBL] [Abstract][Full Text] [Related]
31. Multilocus analysis in candidate genes ACE, AGT, and AGTR1 and predisposition to peripheral arterial disease: role of ACE D/-240T haplotype.
Fatini C; Sticchi E; Sofi F; Said AA; Pratesi G; Pulli R; Pratesi C; Abbate R
J Vasc Surg; 2009 Dec; 50(6):1399-404. PubMed ID: 19782519
[TBL] [Abstract][Full Text] [Related]
32. Association between polymorphisms of the renin-angiotensin system genes and breast cancer risk: a meta-analysis.
Xi B; Zeng T; Liu L; Liang Y; Liu W; Hu Y; Li J
Breast Cancer Res Treat; 2011 Nov; 130(2):561-8. PubMed ID: 21638051
[TBL] [Abstract][Full Text] [Related]
33. Preventing end-stage renal disease in diabetic patients - dual blockade of the renin-angiotensin system (Part II).
Jacobsen PK
J Renin Angiotensin Aldosterone Syst; 2005 Sep; 6(2):55-68. PubMed ID: 16470484
[TBL] [Abstract][Full Text] [Related]
34. Pharmacogenetic interactions between angiotensin-converting enzyme inhibitor therapy and the angiotensin-converting enzyme deletion polymorphism in patients with congestive heart failure.
McNamara DM; Holubkov R; Postava L; Janosko K; MacGowan GA; Mathier M; Murali S; Feldman AM; London B
J Am Coll Cardiol; 2004 Nov; 44(10):2019-26. PubMed ID: 15542286
[TBL] [Abstract][Full Text] [Related]
35. Renin-angiotensin gene polymorphisms in relation to severe chronic periodontitis.
Gürkan A; Emingil G; Saygan BH; Atilla G; Köse T; Baylas H; Berdeli A
J Clin Periodontol; 2009 Mar; 36(3):204-11. PubMed ID: 19236533
[TBL] [Abstract][Full Text] [Related]
36. Genetic polymorphisms of renin-angiotensin system and progression of interstitial nephritis.
Buraczyńska M; Grzebalska A; Spasiewicz D; Orłowska G; Ksiazek A
Ann Univ Mariae Curie Sklodowska Med; 2002; 57(2):330-6. PubMed ID: 12898858
[TBL] [Abstract][Full Text] [Related]
37. Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers for prevention and treatment of nephropathy associated with type 2 diabetes mellitus.
Hughes DB; Britton ML
Pharmacotherapy; 2005 Nov; 25(11):1602-20. PubMed ID: 16232022
[TBL] [Abstract][Full Text] [Related]
38. Effects of renin-angiotensin system blockers on renal outcomes and all-cause mortality in patients with diabetic nephropathy: an updated meta-analysis.
Sarafidis PA; Stafylas PC; Kanaki AI; Lasaridis AN
Am J Hypertens; 2008 Aug; 21(8):922-9. PubMed ID: 18535536
[TBL] [Abstract][Full Text] [Related]
39. Association of the angiotensinogen M235T and angiotensin-converting enzyme insertion/deletion gene polymorphisms in Turkish type 2 diabetic patients with and without nephropathy.
Eroglu Z; Cetinkalp S; Erdogan M; Kosova B; Karadeniz M; Kutukculer A; Gunduz C; Tetik A; Topcuoglu N; Ozgen AG; Tuzun M
J Diabetes Complications; 2008; 22(3):186-90. PubMed ID: 18413162
[TBL] [Abstract][Full Text] [Related]
40. Use of ACE inhibitors or angiotensin receptor blockers and survival in patients on peritoneal dialysis.
Fang W; Oreopoulos DG; Bargman JM
Nephrol Dial Transplant; 2008 Nov; 23(11):3704-10. PubMed ID: 18567695
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
